Anticonvulsive pharmaceutical compositions
AssigneeInserm (Institut National De La Sante Et De La Recherche Medicale)
InventorsSerge Picaud, Jose Sahel, Qinping Wang, Agnes Duboc, Manuel Simonutti
Life of this patent
Estimating the term…
Abstract
The present invention pertains to pharmaceutical compositions including, as the active ingredients, a combination of vigabatrin and of at least one glutamate receptor activating substance.
Claims19
An anticonvulsive pharmaceutical composition comprising, as the active ingredients, a combination of (i) 4-amino-5-hexenoic acid and (ii) at least one glutamate receptor activating substance.
A method for preventing or treating convulsive disorders of a patient comprising a step of administering to a patient in need thereof a composition comprising a combination of (i) 4-amino-5-hexenoic acid and (ii) at least one glutamate receptor activating substance.
Dependencies are inferred from the claim text.